SHARE-BASED COMPENSATION (Tables)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2021 |
Dec. 31, 2020 |
| Share-based Payment Arrangement [Abstract] |
|
|
| Schedule of share-based payment award, stock options, valuation assumptions |
|
|
|
Three Months Ended
|
| |
|
March 31, 2021
|
|
Expected term
|
|
5.00 – 6.25 |
|
|
Risk-free interest rate
|
|
0.78 – 1.02 |
% |
|
Expected dividend yield
|
|
0.0 |
% |
|
Expected volatility
|
|
90 |
% |
|
|
|
Three Months Ended
|
| |
|
March 31, 2021
|
|
Grant date share price
|
|
$
|
14.40 |
|
|
Risk-free interest rate
|
|
|
0.5 |
% |
|
Expected dividend yield
|
|
|
0.0 |
% |
|
Expected volatility
|
|
|
90 |
% |
|
Expected life (in years)
|
|
|
1.8 – 3.8 |
|
|
|
|
|
Year Ended
|
| |
|
December 31, 2020
|
|
December 31, 2019
|
|
Expected term
|
|
0.14 – 5.00 |
|
2.79 – 5.00 |
|
|
Risk-free interest rate
|
|
0.22 – 0.41% |
|
1.3 – 2.7 |
% |
|
Expected dividend yield
|
|
0.0% |
|
0.0 |
% |
|
Expected volatility
|
|
85% – 90% |
|
80 |
% |
|
| Schedule of share-based payment arrangement, option, activity |
|
|
|
Stock Options
|
|
Weighted-Average Exercise Price
|
|
Weighted-Average Remaining Contractual Term (Years)
|
|
Aggregate
Intrinsic
Value
|
|
Balance as at December 31, 2020
|
|
896,888 |
|
$
|
5.22 |
|
3.96 |
|
$
|
2,889 |
|
Granted
|
|
51,434 |
|
$
|
14.40 |
|
9.92 |
|
|
|
|
Exercised
|
|
|
|
$
|
|
|
—
|
|
$
|
|
|
Forfeited
|
|
|
|
$
|
|
|
—
|
|
|
|
|
Balance as at March 31, 2021
|
|
948,322 |
|
$
|
6.15 |
|
4.06 |
|
$
|
3,922 |
| |
|
|
|
|
|
|
|
|
|
|
|
Vested and expected to vest as at March 31, 2021
|
|
937,041 |
|
$
|
6.10 |
|
4.07 |
|
$
|
3,923 |
| |
|
|
|
|
|
|
|
|
|
|
|
Vested and exercisable as at March 31, 2021
|
|
494,776 |
|
$
|
6.17 |
|
3.71 |
|
$
|
2,102 |
|
|
|
|
Stock
Options
|
|
Weighted-Average Exercise
Price
|
|
Weighted-Average Remaining Contractual Term (Years)
|
|
Aggregate Intrinsic Value
|
|
Balance as at December 31, 2019
|
|
1,195,544 |
|
|
$
|
14.18 |
|
3.21 |
|
$
|
3,194 |
|
Granted
|
|
121,291 |
|
|
$
|
6.71 |
|
3.64 |
|
|
|
|
Exercised
|
|
(88,706 |
)
|
|
$
|
0.24 |
|
—
|
|
$
|
705 |
|
Forfeited
|
|
(331,241 |
)
|
|
$
|
11.86 |
|
—
|
|
|
|
|
Balance as at December 31, 2020
|
|
896,888 |
|
|
$
|
5.22 |
|
3.96 |
|
$
|
2,889 |
|
Vested and expected to vest as at December 31, 2020
|
|
885,607 |
|
|
$
|
5.60 |
|
3.97 |
|
$
|
2,906 |
|
Vested and exercisable as at December 31, 2020
|
|
419,498 |
|
|
$
|
6.80 |
|
3.78 |
|
$
|
944 |
|
| Schedule of unvested restricted stock units roll forward |
|
|
|
Restricted Share Units
|
|
Weighted-Average Grant Date Fair Value
|
|
Unvested as of December 31, 2020
|
|
78,634 |
|
$
|
3.25 |
|
Granted
|
|
338,393 |
|
|
14.33 |
|
Vested
|
|
(7,713) |
|
|
14.40 |
|
Canceled/forfeited
|
|
|
|
|
|
|
Unvested as of March 31, 2021
|
|
409,314 |
|
$
|
12.47 |
|
|
|
Restricted Share Units
|
|
Weighted-Average Grant Date Fair Value
|
|
Unvested as of December 31, 2020
|
|
|
|
$
|
|
|
Granted
|
|
1,038,718 |
|
|
13.89 |
|
Vested
|
|
|
|
|
|
|
Canceled/forfeited
|
|
|
|
|
|
|
Unvested as of March 31, 2021
|
|
1,038,718 |
|
$
|
13.89 |
|
|
|
|
Restricted
Share Units
|
|
Weighted-Average
Grant Date
Fair Value
|
|
Unvested as of December 31, 2019
|
|
|
|
|
$
|
|
|
Granted
|
|
83,715 |
|
|
|
3.25 |
|
Vested
|
|
(2,989 |
)
|
|
|
3.25 |
|
Canceled/forfeited
|
|
(2,092 |
)
|
|
|
3.25 |
|
Unvested as of December 31, 2020
|
|
78,634 |
|
|
$
|
3.25 |
|